Geographic access to fertility counseling among adolescent and young adult women with cancer in North Carolina.
Cancer Epidemiol Biomarkers Prev
; 2024 Jul 09.
Article
em En
| MEDLINE
| ID: mdl-38980745
ABSTRACT
BACKGROUND:
Fertility counseling is recommended for adolescent and young adult (AYA) women facing gonadotoxic cancer therapy. However, fertility care is subspecialized medical care offered at a limited number of institutions, making geographic access a potential barrier to guideline-concordant care. We assessed the relationship between geographic access and receipt of fertility counseling among AYA women with cancer.METHODS:
Using data from the North Carolina Central Cancer Registry, we identified women diagnosed with lymphoma, gynecologic cancer, or breast cancer at ages 15-39 years during 2004-2015. Eligible women were invited to complete an online survey on various topics, including fertility counseling. Geographic access was measured, using geocoded addresses, as vehicular travel time from residence to the nearest fertility clinic available at diagnosis. Multivariable regression models were used to examine the association between travel time and receipt of fertility counseling by provider type health care provider vs fertility specialist.RESULTS:
Analyses included 380 women. Median travel time to a fertility clinic was 31 (IQR 17-71) minutes. Overall, 75% received fertility counseling from a health care provider and 16% by a fertility specialist. Women who lived ≥30 minutes from a clinic were 13% less likely to receive fertility counseling by a health care provider (PR0.87; 95% CI0.75-1.00) and 49% less likely to receive counseling by a fertility specialist (PR0.51; 95% CI0.28-0.93).CONCLUSIONS:
Women who lived further away from fertility clinics were less likely to receive fertility counseling. IMPACT Interventions to improve access to fertility counseling should include strategies to alleviate the burden of geographic access.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Revista:
Cancer Epidemiol Biomarkers Prev
Assunto da revista:
BIOQUIMICA
/
EPIDEMIOLOGIA
/
NEOPLASIAS
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Estados Unidos